CAS: 10150-93-3 - Ethyl (2E)-4-oxo-2-pentenoate
Formula:C7H10O3
InChI:InChI=1S/C7H10O3/c1-3-10-7(9)5-4-6(2)8/h4-5H,3H2,1-2H3/b5-4+
InChI key:InChIKey=RYESNZCDHSIFDI-SNAWJCMRSA-N
SMILES:O=C(OCC)C=CC(=O)C
- Synonyms:
- (E)-Ethyl 4-oxo-2-pentenoate
- 2-Pentenoic acid, 4-oxo-, ethyl ester, (E)-
- 2-pentenoic acid, 4-oxo-, ethyl ester, (2E)-
- Ethyl (2E)-4-oxo-2-pentenoate
- Ethyl (2E)-4-oxopent-2-enoate
- Ethyl trans-4-oxo-2-pentenoate
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 2-Pentenoic acid, 4-oxo-, ethyl ester, (2E)- REF: IN-DA0004NTCAS: 10150-93-3 | 97% | To inquire | Fri 10 Jan 25 |
 | Ethyl 4-oxopent-2-enoate REF: 54-OR22026CAS: 10150-93-3 | 95% | To inquire | Fri 17 Jan 25 |
 | (E)-ETHYL 4-OXOPENT-2-ENOATE REF: 10-F468807CAS: 10150-93-3 | 95.0% | To inquire | Tue 21 Jan 25 |
 | Ethyl (E)-4-oxopent-2-enoate REF: 3D-KAA15093CAS: 10150-93-3 | Min. 95% | - - - | Discontinued product |
2-Pentenoic acid, 4-oxo-, ethyl ester, (2E)-
CAS:10150-93-3
Formula:
C7H10O3
Purity:
97%
Color and Shape:
Liquid
Molecular weight:
142.1525
Ref: IN-DA0004NT
| 1g | 218.00 € | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 100mg | 101.00 € | ||
| 250mg | 122.00 € | ||
| 500mg | 184.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
Ref: 54-OR22026
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 17 Jan 2025
Ref: 10-F468807
| 1g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ethyl (E)-4-oxopent-2-enoate
CAS:10150-93-3
Ethyl (E)-4-oxopent-2-enoate is an organic compound that is used as a reagent. It is an …
Formula:
C7H10O3
Purity:
Min. 95%
Molecular weight:
142.15 g/mol
Ref: 3D-KAA15093
| 1g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 10g | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
